Seres Therapeutics Inc Stock
Our community is currently low on Seres Therapeutics Inc with 1 Buy predictions and 5 Sell predictions.
A potential of -30.233%, resulting from comparing the current price of €17.20 with the target price of €12.00 for Seres Therapeutics Inc, shows the chance of incurring significant losses.
Our community identified positive and negative aspects for Seres Therapeutics Inc stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Seres Therapeutics Inc stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Seres Therapeutics Inc in the next few years
Performance of Seres Therapeutics Inc vs. its peers
|Seres Therapeutics Inc||5.700%||-5.495%||-21.818%||-||-14.000%||-||-|
|Cara Therapeutics Inc.||2.200%||-3.236%||1.225%||12.384%||25.852%||34.303%||-|
|Minerva Neurosciences Inc.||0.780%||-5.109%||-5.109%||-||41.304%||-||-|